Silicone Breast Implant Postmarket Proposals To Be Weighed By FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA's General & Plastic Surgery Devices Panel is likely to place added scrutiny on Mentor's and Inamed's respective proposed silicone breast implant postmarket studies, given the controversy surrounding the devices and heightened public spotlight on the agency's postmarket data lapses